论文部分内容阅读
目的探究高血压、糖尿病患者临床以硝苯地平药物治疗,患者血压、血糖改善情况。方法 86例高血压、糖尿病患者,按就诊号末位数字单双数将患者分为对照组(用药厄贝沙坦)、观察组(加用硝苯地平缓释片),每组人数均为43例,统计治疗期间用药所致不良反应,检测用药前后血糖、血压水平变化。结果入院时血压、血糖指标组间比较差别无统计学意义(P>0.05),用药后观察组血糖、血压水平降低效果优于对照组,差别具有统计学意义(P<0.05);两组未出现严重不良反应,用药安全性良好。结论综上所述,临床对高血压、糖尿病合并患者,使用硝苯地平缓释片治疗,能提高降糖、降压效果。
Objective To investigate the clinical improvement of hypertension and diabetes in patients treated with nifedipine and blood pressure and blood glucose. Methods Totally 86 patients with hypertension and diabetes were divided into the control group (treated with irbesartan) and the observation group (treated with nifedipine sustained-release tablets) according to the number of single and / 43 cases, statistical treatment of adverse reactions caused by medication, before and after treatment to detect blood glucose and blood pressure levels. Results There were no significant differences in blood pressure and blood glucose between the two groups on admission (P> 0.05). The blood glucose and blood pressure in the observation group were significantly lower than those in the control group (P <0.05) Serious adverse reactions, medication safety is good. Conclusion To sum up, clinical treatment of patients with hypertension and diabetes complicated with nifedipine sustained-release tablets can improve blood glucose and blood pressure.